News

Filter

Current filters:

North Americaaclidinium

Forest Labs and Almirall opt to delay US filing for combo COPD drug

15-08-2013

USA-based Forest Laboratories (NYSE: FRX) and Spain's largest drugmaker Almirall (ALM:MC) said late yesterday…

aclidiniumAlmirallForest LaboratoriesformoterolNorth AmericaPharmaceuticalRegulationRespiratory and PulmonaryTudorza Pressair

Almirall sets up first direct North America presence

05-09-2012

Almirall (ALM: MC), Spain's largest pharmaceutical company, says it has set up a new affiliate in Canada…

aclidiniumAlmirallMarkets & MarketingNorth AmericaPharmaceuticalRespiratory and Pulmonary

US FDA delays approval of Almirall and Forest Laboratories' COPD drug

30-03-2012

The US Food and Drug Administration has said it will require a three-month extension to complete its…

aclidiniumAlmirallEkliraEuropeForest LaboratoriesLicensingMenariniNorth AmericaPharmaceuticalRegulationRespiratory and PulmonaryTudorza Pressair

Forest and Almirall see early filing of COPD drug aclidinium with US FDA; Appointment at Almirall

04-07-2011

Spain’s largest pharma company Almirall (ALM. MC) and US marketing partner Forest Laboratories (NYSE:…

aclidiniumAlmirallEuropeForest LaboratoriesManagementNorth AmericaPharmaceuticalRegulationRespiratory and Pulmonary

COMPANY SPOTLIGHT

Menarini

Back to top